Trimetazidine Blocks Lipid Oxidation-Should it be Repurposed for Prevention and Treatment of Diabetic Ketoacidosis?

J Diabetes Sci Technol. 2022 Sep;16(5):1063-1068. doi: 10.1177/19322968221100196. Epub 2022 Jun 2.
No abstract available

Keywords: SGLT2 inhibitor; ketoacidosis; metabolic modulator; repurpose; trimetazidine.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus*
  • Diabetic Ketoacidosis* / prevention & control
  • Humans
  • Lipids
  • Trimetazidine* / therapeutic use

Substances

  • Blood Glucose
  • Lipids
  • Trimetazidine